Jatoi, A <br/><br/>
A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial.  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Aug 2017 
 - 1957-1963 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdx232  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anorexia--drug therapy<br/>Creatine--pharmacology<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms--complications<br/>Placebos<br/>Weight Loss--drug effects